Home > News Item Detail
Headache in the News ArchiveTherapeutics Daily -- Almotriptan (Axert/Almogran) Approved by the FDA for the Treatment of Migraine in Adolescents
2009 Jun 04 Almotriptan (Axert/Almogran) Approved by the FDA for the Treatment of Migraine in Adolescents
Categories: Research |
Find a headache specialist near you:


